Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Successful prevention of secondary burn progression using infliximab hydrogel: A murine model

Burns(2021)10.1016/j.burns.2021.07.021Source: DataRank Database

Successful prevention of secondary burn progression using infliximab hydrogel: A murine model is a research paper published in Burns (2021). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

11 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.77)OA: closedTopics (42)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Brady Burns ORCID,Alonda C. Pollins ORCID,John A. Rector ORCID,Patrick E. Assi ORCID,Harrison C. Thomas ORCID

Live enrichment

PubMed:34952735 OpenAlex:https://openalex.org/W3189490408

Vanderbilt University

Grant: 1018894

National Institutes of Health

Grant: R01NS110665

BASF

Burroughs Wellcome Fund

FWCI

0.77

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

2026

closedLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S0305417921002072?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0305417921002072?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.burns.2021.07.021

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34952735

Fields of Study

Wound Healing and TreatmentsBurn Injury Management and Outcomes3D Printing in Biomedical ResearchAlginatesAnimalsBurnsDisease Models, AnimalGelatinHumansHydrogelsInflammationInfliximabMiceProspective StudiesTumor Necrosis Factor InhibitorsTumor Necrosis Factor-alpha

MeSH Terms

InfliximabTumor Necrosis Factor InhibitorsAlginatesAnimalsBurnsDisease Models, AnimalGelatinHumansInflammationProspective StudiesTumor Necrosis Factor-alphaHydrogelsMice

Keywords

MedicineTotal body surface areaInflammationSelf-healing hydrogelsInfliximabBurn injurySurgeryTumor necrosis factor alphaInternal medicinehydrogelAnti-tnf-αPartial-thickness BurnBurn Progression

Sustainable Development Goals

SDG 0: Good health and well-being

Successful prevention of secondary burn progression using infliximab hydrogel: A murine model

FAIR Checklist

Authors (11)

Funding (4 grants)

Impact

Open Access

Topics